Skip to content

EMG ss AMG In Robotic/Laparoscopic Surgery

The Impact Of Electromyography Vs Acceleromyography On The Management Of Neuromuscular Block During Robotic And Laparoscopic Surgery: A Randomized Controlled Trial

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07525323
Acronym
PEARL
Enrollment
400
Registered
2026-04-13
Start date
2026-08-31
Completion date
2026-12-31
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery

Brief summary

The purpose of this study is to compare the mean cumulative weight-based/time-corrected rocuronium dose administered in patients undergoing robotic- or laparoscopic- assisted surgery using either acceleromyography or electromyography.

Interventions

DEVICEAMG device

The anesthesia team will use an AMG device to monitor neuromuscular block

DEVICEEMG

The anesthesia team will use an EMG device to monitor neuromuscular block

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> or = 18 years old * Patients willing to participate and provide an integrated, informed consent * Patients undergoing elective laparoscopic- or robotic-assisted surgical procedures * Anticipated surgery duration \< 300 minutes

Exclusion criteria

* Patients with disorders, such as stroke, carpal tunnel syndrome, broken wrist with nerve damage, Dupuytren contracture, or any similar wrist injury. * Patients with systemic neuromuscular diseases such as myasthenia gravis. * Patients having surgery that would involve prepping the arm into the sterile field. * Patients with chronic kidney disease (eGFR \<60).

Design outcomes

Primary

MeasureTime frameDescription
Cumulative rocuronium dosePerioperative/PeriproceduralWeight- and time-adjusted mean cumulative rocuronium dose between the AMG and EMG groups

Secondary

MeasureTime frameDescription
Mean sugammadex dosePerioperative/PeriproceduralMean sugammadex dose between the two groups
Number of rocuronium administrationsPerioperative/PeriproceduralNumber of rocuronium administrations throughout the case,
Frequency of placing a peripheral nerve stimulatorPerioperative/PeriproceduralFrequency of placing a peripheral nerve stimulator
Depth of neuromuscular block prior to sugammadex administrationPerioperative/PeriproceduralDepth of neuromuscular block prior to sugammadex administration

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORJohnathan Renew

Mayo Clinic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 21, 2026